Cargando…

Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients

BACKGROUND: Clinical staging is essential for clinical decisions but remains imprecise. We purposed to construct a novel survival prediction model for improving clinical staging system (cTNM) for patients with esophageal adenocarcioma (EAC). METHODS: A total of 4180 patients diagnosed with EAC were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Chen-ye, Yu, Yue, Li, Qi-fan, Liu, Xiao-long, Song, Hai-zhu, Shen, Yi, Yi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445330/ https://www.ncbi.nlm.nih.gov/pubmed/34540700 http://dx.doi.org/10.3389/fonc.2021.736573

Ejemplares similares

Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma
por: Zhang, Shiyao, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma
por: Wang, Zhenfeng, et al.
Publicado: (2023)

Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
por: Xu, Xiaoming, et al.
Publicado: (2022)

Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma
por: Li, Haoran, et al.
Publicado: (2021)

Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
por: Hu, Jing Feng, et al.
Publicado: (2023)

Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma
por: Tian, Shu, et al.
Publicado: (2021)

Development and Validation of a Prognostic Nomogram for Extremity Soft Tissue Leiomyosarcoma
por: Xue, MingFeng, et al.
Publicado: (2019)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma
por: Lin, Yu, et al.
Publicado: (2023)

Development and Validation of a Prognostic Nomogram to Predict Cancer-Specific Survival in Adult Patients With Pineoblastoma
por: Jing, Yajun, et al.
Publicado: (2020)

Development and Validation of the Individualized Prognostic Nomograms in Patients With Right- and Left-Sided Colon Cancer
por: Luo, Zai, et al.
Publicado: (2021)

Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma
por: Zhao, Fangrui, et al.
Publicado: (2022)

Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma
por: Hou, Chen, et al.
Publicado: (2020)

Construction and Validation of Novel Nomograms for Predicting Prognosis of Pancreatic Ductal Adenocarcinoma After Surgery According to Different Primary Cancer Locations
por: Li, Ge, et al.
Publicado: (2021)

Corrigendum: Development and Validation of a Prognostic Nomogram to Predict Cancer-Specific Survival in Adult Patients With Pineoblastoma
por: Jing, Yajun, et al.
Publicado: (2020)

Development and internal validation of a nomogram for predicting survival of nonoperative EGFR-positive locally advanced elderly esophageal cancers
por: Wang, Jiayang, et al.
Publicado: (2023)

Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram
por: Zhou, Shengnan, et al.
Publicado: (2021)

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics
por: Li, Huijun, et al.
Publicado: (2022)

Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients
por: Wang, Fangqing, et al.
Publicado: (2022)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Development and Validation of a Simple-to-Use Nomogram to Predict Early Death in Metastatic Pancreatic Adenocarcinoma
por: Zhang, Zhong, et al.
Publicado: (2021)

Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy
por: Peng, Feng, et al.
Publicado: (2021)

Development and validation of lymph node ratio-based nomograms for primary duodenal adenocarcinoma after surgery
por: Shi, Jingxiang, et al.
Publicado: (2022)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Construction and validation of a novel nomogram to predict cancer-specific survival in patients with gastric adenocarcinoma
por: Nie, Guole, et al.
Publicado: (2023)

Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit
por: Li, Lin, et al.
Publicado: (2021)

A Nomogram for Predicting the Risk of Radiotherapy-Related Esophageal Fistula in Esophageal Cancer Patients
por: Gui, Zhongxuan, et al.
Publicado: (2022)

Survival analysis and development of a prognostic nomogram for patients with malignant mesothelioma in different anatomic sites
por: Shao, Shengteng, et al.
Publicado: (2022)

Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
por: Yang, Zifeng, et al.
Publicado: (2021)

Development and validation of a population-based prognostic nomogram for primary colorectal lymphoma patients
por: Chen, Qian, et al.
Publicado: (2022)

Development and validation of a nomogram model for the prediction of 4L lymph node metastasis in thoracic esophageal squamous cell carcinoma
por: Xu, Lei, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma
por: Deng, Qing-Long, et al.
Publicado: (2017)

Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung
por: Chen, Zhiyong, et al.
Publicado: (2022)

Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
por: Tong, Jingshu, et al.
Publicado: (2022)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma
por: Li, Qi, et al.
Publicado: (2021)

Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes
por: Jiang, Hui-zhong, et al.
Publicado: (2022)

Development and Validation of a Radiomics Nomogram for Differentiating Pulmonary Cryptococcosis and Lung Adenocarcinoma in Solitary Pulmonary Solid Nodule
por: Zhao, Jiabi, et al.
Publicado: (2021)

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
por: Ren, Xiangqing, et al.
Publicado: (2023)

Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study
por: Chen, Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6g3rg2nj3929r84g1flqekl9d6